KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Elevance Health (ELV) FCF Margin (2016 - 2025)

Elevance Health (ELV) has disclosed FCF Margin for 17 consecutive years, with 3.59% as the latest value for Q2 2025.

  • On a quarterly basis, FCF Margin rose 4788.0% to 3.59% in Q2 2025 year-over-year; TTM through Dec 2025 was 3.22%, a 246.0% decrease, with the full-year FY2025 number at 226.39%, down 22896.0% from a year prior.
  • FCF Margin was 3.59% for Q2 2025 at Elevance Health, up from 1.68% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 17.2% in Q1 2023 to a low of 112.94% in Q4 2024.
  • A 5-year average of 4.62% and a median of 4.83% in 2021 define the central range for FCF Margin.
  • Peak YoY movement for FCF Margin: tumbled -10538bps in 2024, then surged 4788bps in 2025.
  • Elevance Health's FCF Margin stood at 3.14% in 2021, then plummeted by -248bps to 4.66% in 2022, then tumbled by -62bps to 7.56% in 2023, then crashed by -1393bps to 112.94% in 2024, then skyrocketed by 103bps to 3.59% in 2025.
  • Per Business Quant, the three most recent readings for ELV's FCF Margin are 3.59% (Q2 2025), 1.68% (Q1 2025), and 112.94% (Q4 2024).